Novartis to sponsor large clinical trial of hydroxychloroquine in hospitalized COVID-19 patients
April 20, 2020 01:32 ET
|
Novartis International AG
Novartis has reached an agreement with the US Food and Drug Administration (FDA) to proceed with a Phase III clinical trial of hydroxychloroquine in hospitalized patients with COVID-19 disease Trial...
Novartis announces plan to initiate clinical study of Jakavi® in severe COVID-19 patients and establish international compassionate use program
April 02, 2020 17:05 ET
|
Novartis International AG
New clinical trial to evaluate Jakavi® (ruxolitinib) in patients with COVID-19 associated cytokine storm Cytokine storm is a type of severe immune overreaction that can result from coronavirus...
ELISpot and Fluorospot Assay Market To Reach USD 408.8 Million By 2026 | Reports and Data
March 24, 2020 13:00 ET
|
Reports and Data
New York, March 24, 2020 (GLOBE NEWSWIRE) -- According to the current analysis of Reports and Data, the ELISpot and Fluorospot Assay Market was valued at USD 123.5 million in 2018 and is expected to...
HealthEC’s Dr. Jenifer Leaf Jaeger Cited in HUD Report on Infectious Disease Prevention
March 17, 2020 15:14 ET
|
HealthEC
EDISON, N.J., March 17, 2020 (GLOBE NEWSWIRE) -- HealthEC, LLC the 2019 Best in KLAS provider of population health management solutions, today announced that Senior Medical Director Jenifer Leaf...
Global Genetic Testing Services Market is Expected to Reach USD 67.1 Billion by 2025 : Fior Markets
February 25, 2020 20:00 ET
|
Fior Markets
Newark, NJ, Feb. 25, 2020 (GLOBE NEWSWIRE) -- As per the report published by Fior Markets, the global genetic testing services market is expected to grow from USD 34.5 Billion in 2017 to USD 67.1...
Beroni Group to Present at Biotech Showcase™ 2020 in San Francisco, USA
December 19, 2019 09:30 ET
|
Beroni Group Limited
NEW YORK and SYDNEY, Australia, Dec. 19, 2019 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an international diversified biopharmaceutical enterprise focused...
Co-Diagnostics (NASDAQ:CODX) Gets “Indian FDA” Approval for Infectious Disease Testing in One of the World’s Biggest Markets
December 03, 2019 09:00 ET
|
BDA International
New York City, Dec. 03, 2019 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (Nasdaq: CODX), a biotech company with a patented platform for the development of molecular diagnostic tests, released what...
Enochian Biosciences Expands its Infectious Disease Pipeline by Entering into an Agreement in Principle to Acquire an Exclusive License for a Novel Hepatitis B Virus Treatment
November 25, 2019 07:00 ET
|
Enochian Biosciences, Inc.
Agreement provides Enochian with exclusive rights to develop and commercialize a HBV treatment with a novel mechanism of actionAbstract accepted highlighting the in vivo and in vitro data from...
Biologics Market To Reach USD 625.6 Million By 2026 | Reports And Data
October 10, 2019 12:54 ET
|
Reports and Data
New York, Oct. 10, 2019 (GLOBE NEWSWIRE) -- Rise in prevalence of target chronic diseases like cancer, increase in unhealthy lifestyle habits, mergers and acquisitions by major companies, product...
Global Molecular Quality Controls Market is Expected to Reach USD 271.98 Million by 2025 : Fior Markets
September 30, 2019 09:28 ET
|
Fior Markets
New Jersey, NJ, Sept. 30, 2019 (GLOBE NEWSWIRE) -- The key contributing factor for the molecular quality controls market growth are rising number of indorsed clinical laboratories, emergent adoption...